Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Monsanto Company (MON), Syngenta AG (ADR) (SYT): The Two Sides of the GMO Debate

Page 1 of 2

Last week, over 2 million protesters in 436 cities across 52 countries rallied against agricultural giant Monsanto Company (NYSE:MON) and genetically modified crops. While I haven’t been a big fan of some of Monsanto’s business practices, as I have outlined in the past, I believe that these protests have sent the wrong message regarding GMOs (genetically modified organisms) and the genetically modified seeds industry in general.

genetically modified foods

Despite the constant vilification of Monsanto Company (NYSE:MON), and to a lesser extent, its peers Syngenta AG (ADR) (NYSE:SYT) and E I Du Pont De Nemours And Co (NYSE:DD), these agricultural companies produce ingeniously engineered seeds that are able to withstand herbicides, grow in arid environments, and produce higher yields. These three qualities will all be increasingly important as the world’s population, now at 7 billion, rises to an estimated 9 billion by 2050. With all those extra mouths to feed – which will coincide with a rapid decrease in the amount of arable land – farmers will need all the help they can get to produce staple crops such as soybeans, corn and cotton at profitable margins.

Therefore, are protesters right to demand that food companies that use GMOs label their products accordingly, which could spook consumers and lead to sales declines, or are GMOs merely scientifically improved products that are as safe for human consumption as their naturally grown peers? Should we be thankful for the new products that genetically modified seed companies have created, or should we be fearful of the long-term implications of their continued dominance of the agricultural industry? Let’s take a look at both sides of the argument.

What the critics claim

The critics tend to highlight a supposedly shocking fact – that Monsanto Company (NYSE:MON), along with The Dow Chemical Company (NYSE:DOW), created Agent Orange, the highly toxic herbicide that was used during the Vietnam War to clear forests to deprive enemy guerrilla soldiers of their cover. That herbicide, they argue, eventually evolved into Monsanto’s Roundup herbicide (glyphosate), the company’s best-selling product that is paired up with “Roundup Ready” genetically modified seeds. Roundup Ready seeds are resistant to Roundup herbicide, which makes clearing weeds an extremely efficient task.

Yet the critics claim that this technology has unknown health risks, which have beenhighlighted by independent scientific studies. Glyphosate has also been found to contaminategroundwater, leading to the increased risk of human consumption.

The FDA’s official position is that GMOs are safe and carry no adverse health risks. The reason for this opinion, Monsanto Company (NYSE:MON)’s opponents claim, is that Monsanto executives have a symbioticrelationship with the FDA, in which former Monsanto executives often hold on to high-ranking positions in the FDA to ensure that favorable legislation is passed. For example, FDA deputy commissioner of the Office of Foods Michael R. Taylor was once the Vice President of Public Policy at Monsanto. Therefore, even though 64 countries around the world require GMO labeling, the United States still only encourages voluntary labeling.

Monsanto Company (NYSE:MON) has also been criticized for suing farmers that violated its seed saving rules. Under Monsanto’s contracts, farmers are not allowed to save seeds from current crops and replant them, and must purchase new seeds every season. For Monsanto, it is a matter of patent protection, but for most of the farmers that it has sued, it usually results in total bankruptcy.

For critics, Monsanto Company (NYSE:MON) has all the characteristics of an “evil corporation” – allegedly producing unsafe products, controlling governing bodies, and burying individuals over contract violations. But that’s only half the story.

What the GMO companies think

What GMO critics don’t realize is that a world without Monsanto, E I Du Pont De Nemours And Co (NYSE:DD) and Syngenta AG (ADR) (NYSE:SYT) would be a radically different one.

The recent drought in the Great Plains, which some believe to be the result of climate change, would have made planting corn impossible if it weren’t for drought-tolerant seeds from E I Du Pont De Nemours And Co (NYSE:DD). Last quarter, DuPont reported brisk sales of its Optimum AQUAmax corn, which can grow in drier conditions. Demand for these products boosted DuPont’s agriculture segment 14% year-on-year to $4.67 billion, accounting for 45% of the company’s top line.

Monsanto Company (NYSE:MON), in contrast, lacks a viable drought-resistant corn seed, after its original attempt failedin 2012. Monsanto is currently working on a new drought-resistant corn seed with chemical giant BASF. For now, Monsanto’s strength in corn comes from Bt, a pesticide that grows directly in the crop and later breaks down upon being reaped. Monsanto and Syngenta AG (ADR) (NYSE:SYT) notably produce “triple stacked” corn, which is resistant to corn borers, corn rootworms, and herbicides.

This focus on corn makes a lot of sense, considering that the price of corn has risen 180% over the past decade. Without GMOs, corn prices – which are connected to soda, snack, cereal, bio-fuels and meat prices – would skyrocket. Therefore, GMO companies keep crop prices (which are already heavily subsidized) under control and allow farmers to continue making profits. This explains the U.S. government’s unwavering support of Monsanto Company (NYSE:MON) – the alternative to GMO crops would be unshackled food inflation that would cripple the country’s food chain and force the government to raise subsidies.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!